|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
HU196714B
(en)
|
1984-10-04 |
1989-01-30 |
Monsanto Co |
Process for producing non-aqueous composition comprising somatotropin
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
PH30995A
(en)
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
AU6242096A
(en)
|
1995-06-27 |
1997-01-30 |
Takeda Chemical Industries Ltd. |
Method of producing sustained-release preparation
|
|
TW448055B
(en)
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
|
JP2909418B2
(ja)
|
1995-09-18 |
1999-06-23 |
株式会社資生堂 |
薬物の遅延放出型マイクロスフイア
|
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
|
US6264970B1
(en)
|
1996-06-26 |
2001-07-24 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
|
PT839525E
(pt)
|
1996-10-31 |
2004-10-29 |
Takeda Chemical Industries Ltd |
Preparacao de libertacao prolongada
|
|
WO1998027980A2
(en)
|
1996-12-20 |
1998-07-02 |
Takeda Chemical Industries, Ltd. |
Method of producing a sustained-release preparation
|
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
|
KR19990085365A
(ko)
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
AU2017373758B2
(en)
|
2016-12-07 |
2021-12-16 |
Orimos Therapeutics Co., Ltd. |
Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof
|
|
GB201810092D0
(en)
|
2018-06-20 |
2018-08-08 |
Ctxt Pty Ltd |
Compounds
|
|
GB201810581D0
(en)
*
|
2018-06-28 |
2018-08-15 |
Ctxt Pty Ltd |
Compounds
|
|
DK4299135T3
(da)
*
|
2019-06-18 |
2025-09-08 |
Pfizer |
Benzisoxazol-sulfonamid-derivater
|
|
US12545669B2
(en)
|
2019-06-19 |
2026-02-10 |
Pfizer Inc. |
Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives
|
|
FI4181920T3
(fi)
|
2020-07-15 |
2025-11-20 |
Pfizer |
Kat6-estäjämenetelmät ja yhdistelmät syövän hoitoon
|
|
WO2022081842A1
(en)
|
2020-10-16 |
2022-04-21 |
The Broad Institute, Inc. |
Substituted acyl sulfonamides for treating cancer
|
|
US20240279207A1
(en)
|
2020-10-16 |
2024-08-22 |
The Broad Institute, Inc. |
Substituted acyl sulfonamides for treating cancer
|
|
US20240254139A1
(en)
|
2021-05-21 |
2024-08-01 |
Aurigene Oncology Limited |
Fused isoxazolyl compounds as kat6a inhibitors
|
|
CA3225068A1
(en)
|
2021-07-05 |
2023-01-12 |
Hangzhou Innogate Pharma Co., Ltd. |
Compound serving as kat6 inhibitor
|
|
CN115594695A
(zh)
|
2021-07-09 |
2023-01-13 |
江苏恒瑞医药股份有限公司（Cn） |
大环类化合物、其制备方法及其在医药上的应用
|
|
CN115611877A
(zh)
|
2021-07-12 |
2023-01-17 |
江苏恒瑞医药股份有限公司 |
磺酰胺类化合物、其制备方法及其在医药上的应用
|
|
EP4360341A1
(en)
|
2021-08-05 |
2024-05-01 |
Google Llc |
Managing paging for multicast and broadcast services
|
|
US20250145637A1
(en)
|
2021-08-10 |
2025-05-08 |
Jiangsu Hengrui Pharmaceuticals Co. Ltd. |
Sulfonamide derivative, preparation method therefor and medical use thereof
|
|
CN118556053A
(zh)
|
2021-11-16 |
2024-08-27 |
英矽智能科技知识产权有限公司 |
赖氨酸乙酰基转移酶6a(kat6a)抑制剂及其用途
|
|
WO2023114710A1
(en)
|
2021-12-13 |
2023-06-22 |
Aurigene Oncology Limited |
Fused benzoisoxazolyl compounds as kat6a inhibitors
|
|
CN118234497A
(zh)
|
2021-12-15 |
2024-06-21 |
丹娜-法伯癌症研究所 |
通过破坏menin-mll表观遗传复合体靶向治疗胃肠道间质瘤(gist)
|
|
KR20250006833A
(ko)
*
|
2022-03-28 |
2025-01-13 |
아이소스테릭스, 인코포레이티드 |
라이신 아세틸 전이효소의 myst 계열의 억제제
|
|
CN115073392B
(zh)
|
2022-05-30 |
2023-09-12 |
中美（河南）荷美尔肿瘤研究院 |
N,n-二乙基磺酰胺二取代的苯并噻唑类衍生物、其制备方法及应用
|